Abstract: Cancer treatment has been marred by the fact that most drugs target cancer cells as well as normal cells. Gene therapy is one of a handful of methods that will make cancer cells "stand out," allowing drugs or the host's immune system to selectively target cancer cells. ... Read more
 |
In a collaboration between Discovery Medicine and Johns Hopkins School of Medicine CME, certain articles published by Discovery Medicine will be certified by Johns Hopkins as a Johns Hopkins CME series. These articles will be labeled "Hopkins CME." |
||
List of 100 Random Tags: (or View All Tags)
ACTH advanced breast cancer angiogenesis anisomycin antibody-drug conjugate antigen-presenting cell APP appetite regulation atacicept bacterial cell wall beta-amyloid precursor protein biotech investing BMI BRAF BRCA2 caloric restriction catalytic antibody CEA chemotaxis chitosan chromosome chromosome translocation cocktail therapy cognitive functioning cyclic heptapeptide DCE-US degradomics developmental plasticity DNA methylation dsRNA E1A epidermal growth factor epigenetic silencing epithelial mesenchymal interaction EPO exon skipping frizzled related protein GABA genetic predisposition genomic instability gp120 GPCR hearing loss hemagglutinin HIV detection HPV vaccine hypusine IFN-alpha IFN-gamma IL-33 IL-8 imetelstat inflammasome inflammation inhibitor of apoptosis inotuzumab ozogamicin interferon regulatory factor 5 intraocular pressure IQ karyotype loss of heterozygosity MAPC melanocortin methylguanine-DNA-methyltransferase microsatellite DNA mitochondrial dysfunction mitochondrial trifunctional protein ncRNA neuropeptide Y neuroprotection NOS2 omalizumab p16 phagocytosis platelet activating factor receptor pleomorphic form poliovirus genome postmenopausal osteoporosis presenilin prostatic acid phosphatase protein chip proteinase activated receptor PTEN radiation-induced mutation SARS-CoV secretase senescence shiga toxin single nucleotide polymorphism small interfering RNA SSRIs stem cell homing TMPT TNFSF4 tumor associated antigen type 1 interferon VEGF virus-like particle vitamin K xenotransplantation
